Email Updates
Commentary
Sidelining safety — the FDA's inadequate response to the IOM.
February 17, 2011
Smith SW. N Engl J Med. 2007;357(10):960-3.
In this perspective, the author discusses how the organizational culture of the US Food and Drug Administration (FDA) must change to foster a culture of safety.
